Management of Women With Acquired Cardiovascular Disease From Pre-Conception Through Pregnancy and Postpartum: JACC Focus Seminar 3/5.

Acquired cardiovascular conditions are a leading cause of maternal morbidity and mortality. A growing number of pregnant women have acquired and heritable cardiovascular conditions and cardiovascular risk factors. As the average age of childbearing women increases, the prevalence of acute coronary syndromes, cardiomyopathy, and other cardiovascular complications in pregnancy are also expected to increase. This document, the third of a 5-part series, aims to provide practical guidance on the management of such conditions encompassing pre-conception through acute management and considerations for delivery.

Informations de copyright

Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Funding Support and Author Disclosures Supported by grants from the National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI) to Dr. Bello (K23 HL136853-03, R01 HL153382-01), and Dr. Shah (5K08HL136850, Women As One); from the Clinical and Translational Science Institute (CTSI) to Dr. Minissian (F31NR015725; CTSI support UL1TR000124 and UL1TR001881-01); and the Preventive Cardiovascular Nurses Association through the American Nurses Foundation (#5362). Additional support was provided by the Cedars-Sinai Department of Obstetrics and Gynecology, Geri and Richard Brawerman Nursing Institute, Simms/Mann Family Foundation, Department of Nursing Research, Barbra Streisand Women’s Heart Center. Beta Chi Chapter. Cedars-Sinai Precision Health Institute (#42254). Dr. Park has received funding from Abbott. Dr. Bairey Merz has received research grants from Sanofi and Abbott; has received consulting fees from Bayer; and has served on the board for rRhythm. Dr. Minissian has received consulting fees from Amgen, Vox Media, Medtelligence, Minneapolis Heart Institute, Primed, Good Samaritan Hospital, Los Angeles, California, Cardiometabolic Health Congress, American Heart Association, National Lipid Association, Preventive Cardiovascular Nurses Association, and the American College of Cardiology; and has been a medical advisory board member for the North American Center for Continuing Medical Education, LLC. Dr. Reynolds has received in-kind donations for unrelated studies from Abbott Vascular, Siemens, and BioTelemetry. Dr. Volgman has stock ownership in Apple Inc. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.